公开(公告)号：LT2328618T

公开(公告)日：2018-03-26

申请号：LT09789125

申请日：2009-08-13

Applicant: VERTEX PHARMA

Inventor： ROWE WILLIAM ,  HURTER PATRICIA ,  YOUNG CHRISTOPHER ,  DINEHART KIRK ,  VERWIJS MARINUS JACOBUS ,  OVERHOFF KIRK ,  GROOTENHUIS PETER D J ,  BOTFIELD MARTYN ,  GROSSI ALFREDO

IPC: A61K47/32 ,  A61K9/16 ,  A61K9/20 ,  A61K9/28 ,  A61K31/47

公开(公告)号：HRP20170682T1

公开(公告)日：2017-07-14

申请号：HRP20170682

申请日：2017-05-05

Applicant: VERTEX PHARMA

Inventor： HURTER PATRICIA ,  GONG YUCHUAN ,  YOUNG CHRISTOPHER R ,  CONNELLY PATRICK ,  ROWE WILLIAM ,  COSTACHE ADRIANA ,  KRAWIEC MARIUSZ ,  FENG YUSHI ,  TRUDEAU MARTIN

IPC: C07D215/56 ,  A61K31/445

公开(公告)号：DK1993360T3

公开(公告)日：2017-05-22

申请号：DK06848237

申请日：2006-12-28

Applicant: VERTEX PHARMA

Inventor： HURTER PATRICIA ,  GONG YUCHUAN ,  YOUNG CHRISTOPHER R ,  CONNELLY PATRICK ,  ROWE WILLIAM ,  COSTACHE ADRIANA ,  KRAWIEC MARIUSZ ,  FENG YUSHI ,  TRUDEAU MARTIN

IPC: C07D215/56 ,  A61K31/445

公开(公告)号：EA021706B1

公开(公告)日：2015-08-31

申请号：EA201170330

申请日：2009-08-13

Applicant: VERTEX PHARMA

Inventor： ROWE WILLIAM ,  HURTER PATRICIA ,  YOUNG CHRISTOPHER ,  DINEHART KIRK ,  VERWIJS MARINUS JACOBUS ,  OVERHOFF KIRK ,  GROOTENHUIS PETER D J ,  BOTFIELD MARTYN ,  GROSSI ALFREDO

IPC: A61K47/32

Abstract: Изобретениеотноситсяк областифармацевтики, аименнок таблетке, содержащейтвердуюдисперсию N-[2,4-бис-(1,1-диметилэтил)-5-гидроксифенил]-1,4-дигидро-4-оксохинолин-3-карбоксамидаи способуеевведения. Заявленнаятаблеткахарактеризуетсяхорошейрастворимостьюи высокойстабильностью.

公开(公告)号：NZ597823A

公开(公告)日：2014-05-30

申请号：NZ59782310

申请日：2010-02-18

Applicant: VERTEX PHARMA

Inventor： ROWE WILLIAM ,  HURTER PATRICIA ,  YOUNG CHRISTOPHER R ,  DINEHART KIRK ,  VERWIJS MARINUS JACOBUS ,  OVERHOFF KIRK ,  GROOTENHUIS PETER D J ,  BOTFIELD MARTYN ,  GROSSI ALFREDO ,  ZLOKARNIK GREGOR ,  VAN GOOR FREDRICK F

IPC: A61K9/14 ,  A61K31/47 ,  A61P19/00 ,  A61P19/10 ,  A61P43/00

Abstract: 597823 Disclosed herein are pharmaceutical compositions comprising a solid dispersion of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (compound 1) for use treating or lessening the severity of cystic fibrosis in a patient, and method of manufacturing said compositions. In a preferred embodiment the patient possesses a cystic fibrosis transmembrane receptor (CFTR) with a &Dgr;F508 mutation or G551D mutation on both alleles.

公开(公告)号：HK1161140A1

公开(公告)日：2012-08-24

申请号：HK12102076

申请日：2012-02-29

Applicant: VERTEX PHARMA

Inventor： ROWE WILLIAM ,  HURTER PATRICIA ,  YOUNG CHRISTOPHER ,  DINEHART KIRK ,  VERWIJS MARINUS JACOBUS ,  OVERHOFF KIRK ,  GROOTENHUIS PETER D J ,  BOTFIELD MARTYN ,  GROSSI ALFREDO

IPC: A61K20060101

Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.

公开(公告)号：CA2769695A1

公开(公告)日：2011-02-17

申请号：CA2769695

申请日：2010-02-18

Applicant: VERTEX PHARMA

Inventor： ROWE WILLIAM ,  HURTER PATRICIA ,  YOUNG CHRISTOPHER R ,  DINEHART KIRK ,  OVERHOFF KIRK ,  GROOTENHUIS PETER D J ,  BOTFIELD MARTYN ,  GROSSI ALFREDO ,  ZLOKARNIK GREGOR ,  VAN GOOR FREDRICK F ,  VERWIJS MARINUS JACOBUS

IPC: A61K9/14 ,  A61K31/47 ,  A61P19/00 ,  A61P19/10 ,  A61P43/00

Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis( 1, 1 -dimethylethyl)-5-hydroxyphenyl]- 1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.

公开(公告)号：CA2635581A1

公开(公告)日：2007-07-12

申请号：CA2635581

申请日：2006-12-28

Applicant: VERTEX PHARMA

Inventor： CONNELLY PATRICK ,  COSTACHE ADRIANA ,  KRAWIEC MARIUSZ ,  GONG YUCHUAN ,  HURTER PATRICIA ,  YOUNG CHRISTOPHER R ,  FENG YUSHI ,  TRUDEAU MARTIN ,  ROWE WILLIAM

IPC: A01N43/40 ,  A61K31/445

Abstract: The present invention relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.

公开(公告)号：HUE053357T2

公开(公告)日：2021-06-28

申请号：HUE17204189

申请日：2009-08-13

Applicant: VERTEX PHARMA

Inventor： ROWE WILLIAM ,  HURTER PATRICIA ,  YOUNG CHRISTOPHER ,  DINEHART KIRK ,  VERWIJS MARINUS JACOBUS ,  OVERHOFF KIRK ,  GROOTENHUIS PETER D J ,  BOTFIELD MARTYN ,  GROSSI ALFREDO

IPC: A61K9/16 ,  A61K9/20 ,  A61K9/28 ,  A61K31/47

公开(公告)号：CY1122861T1

公开(公告)日：2021-05-05

申请号：CY201100244

申请日：2020-03-17

Applicant: VERTEX PHARMA

Inventor： HURTER PATRICIA ,  GONG YUCHUAN ,  YOUNG CHRISTOPHER R ,  CONNELLY PATRICK ,  ROWE WILLIAM ,  COSTACHE ADRIANA ,  KRAWIEC MARIUSZ ,  FENG YUSHI ,  TRUDEAU MARTIN

IPC: C07D215/56 ,  A61K31/445

Abstract: ΗπαρούσαεφεύρεσηαφοράσεστερεάςκατάστασηςμορφέςτουΝ-[2,4-δις(1,1-διμεθυλαιθυλ)-5-υδροξυφαινυλ]-1,4-διυδρο-4-οξοκινολινο-3-καρβοξαμιδίου (Ένωση 1), φαρμακευτικέςσυνθέσειςαυτούκαιμεθόδουςμεαυτό.